Pyrimido(4,5-g)chinazolinderivate mit Antitumorwirkung

Pyrimido(4,5-g)quinazoline derivatives with anti-tumour activity

Dérivés de la pyrimido(4,5-g)quinazoline à activité antitumorale


Pyrimido[4,5- g ]quinazoline quinone derivatives were synthesized as anthraquinone-like reductive alkylating agents. Like many naturally-occurring antibiotics, these quinone derivatives are designed to afford an alkylating quinone methide species upon reduction and leaving group elimination. Kinetic studies of pyrimido[4,5- g ]quinazoline hydroquinones provided evidence of quinone methide intermediates able to trap nucleophiles (alkylation) and protons. The rate of quinone methide formation is determined by the hydroquinone free energy. Thus, a linear free energy relationship for quinone methide formation was obtained by plotting rates of quinone methide formation, as the log, versus the quinone reduction potential. The pyrimido[4-5- g ]quinazoline quinone methides fall on this free energy plot, showing that these species are formed by the same mechanism as the other structurally-diverse quinone methides previously studied in this research group. A drawback of many quinone antibiotics, particularly the anthracyclines, is the formation of toxic oxygen species by quinone/hydroquinone cycling. In the present invention pyrimido[4,5- g ]quinazoline hydroquinones are found to be relatively stable toward oxygen, and thus cause little oxygen toxicity. Antitumor screening revealed that the disclosed pyrimid [4,5- g ] quinazoline dione and tetione derivatives possess excellent inhibitory activity against selected human cancer cell lines.




Download Full PDF Version (Non-Commercial Use)

Patent Citations (1)

    Publication numberPublication dateAssigneeTitle
    US-4577018-AMarch 18, 1986American Cyanamid Company2,3-Diamino-substituted-4(3H)-pyrimidinones and platinum chelates

NO-Patent Citations (2)

    JOURNAL OF ORGANIC CHEMISTRY. vol. 53, no. 18, 2 September 1988, EASTON US pages 4209 - 4218 EDWARD B.SKIBO ET AL 'Synthesis and electrochemistry of pyrimidoquinazoline-5,10-diones.Design of hydrolytically stable high potential quinones and new reductive alkylation systems'
    JOURNAL OF ORGANIC CHEMISTRY. vol. 53, no. 26, 23 December 1988, EASTON US pages 6099 - 6105 ROBERT H. LEMUS ET AL 'Studies of extended quinones methides. Design of reductive alkylating agents based on the quinazoline ring system.'

Cited By (8)

    Publication numberPublication dateAssigneeTitle
    EP-1033369-A1September 06, 2000Tets, Viktor Veniaminovich5h-pyrano[2,3-d:6,5-d']dipyrimidin-derivate mit antibakterieller, antiviraler und immunmodulatorischer wirkung
    EP-1873199-A1January 02, 2008Ciba Specialty Chemicals Holding Inc.In-can stabilizers
    US-6340755-B1January 22, 2002Natural Drug Sciences Llc5H-Pyrano[2,3-d: 6,5-d']dipyrimidine derivatives having an antibacterial, antiviral and immuno-modulating activity
    WO-2004035576-A2April 29, 2004Gilead Sciences, Inc.Composés tricycliques préorganisés inhibiteurs d'intégrase
    WO-2004035576-A3June 24, 2004Gilead Sciences Inc, James M Chen, Xiaowu Chen, Maria Fardis, Haolun Jin, Choung U Kim, Laura N SchachererComposés tricycliques préorganisés inhibiteurs d'intégrase
    WO-2004035577-A2April 29, 2004Gilead Sciences, Inc.Pre-organized tricyclic integrase inhibitor compounds
    WO-2004035577-A3July 29, 2004Gilead Sciences Inc, James M Chen, Xiaowu Chen, Maria Fardis, Haolun Jin, Choung U Kim, Laura N SchachererComposes tricycliques pre-organises inhibiteurs d'integrase